Literature DB >> 9836305

The emergence of drug-resistant malaria.

I M Hastings1, M J Mackinnon.   

Abstract

Stochastic processes play a vital role in the early stages of the evolution of drug-resistant malaria. We present a simple and flexible method for investigating these processes and understanding how they affect the emergence of drug-resistant malaria. Qualitatively different predictions can be made depending on the biological and epidemiological factors which prevail in the field. Intense intra-host competition between co-infecting clones, low numbers of genes required to encode resistance, and high drug usage all encourage the emergence of drug resistance. Drug-resistant forms present at the time drug application starts are less likely to survive than those which arise subsequently; survival of the former largely depends on how rapidly malaria population size stabilizes after drug application. In particular, whether resistance is more likely to emerge in areas of high or low transmission depends on malaria intra-host dynamics, the level of drug usage, the population regulation of malaria, and the number of genes required to encode resistance. These factors are discussed in relation to the practical implementation of drug control programmes.

Entities:  

Mesh:

Year:  1998        PMID: 9836305     DOI: 10.1017/s0031182098003291

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  13 in total

1.  Evolutionary trade-offs at two time-scales: competition versus persistence.

Authors:  M Keeling
Journal:  Proc Biol Sci       Date:  2000-02-22       Impact factor: 5.349

Review 2.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

3.  Approximations for the hitchhiking effect caused by the evolution of antimalarial-drug resistance.

Authors:  Kristan A Schneider; Yuseob Kim
Journal:  J Math Biol       Date:  2010-07-11       Impact factor: 2.259

4.  Meiotic recombination, cross-reactivity, and persistence in Plasmodium falciparum.

Authors:  F E McKenzie; M U Ferreira; J K Baird; G Snounou; W H Bossert
Journal:  Evolution       Date:  2001-07       Impact factor: 3.694

5.  An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistance.

Authors:  Kristan A Schneider; Yuseob Kim
Journal:  Theor Popul Biol       Date:  2010-06-19       Impact factor: 1.570

6.  The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant Plasmodium falciparum.

Authors:  Thiery Masserey; Tamsin Lee; Monica Golumbeanu; Andrew J Shattock; Sherrie L Kelly; Ian M Hastings; Melissa A Penny
Journal:  Elife       Date:  2022-07-07       Impact factor: 8.713

7.  Transmission intensity and drug resistance in malaria population dynamics: implications for climate change.

Authors:  Yael Artzy-Randrup; David Alonso; Mercedes Pascual
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 8.  Global transport networks and infectious disease spread.

Authors:  A J Tatem; D J Rogers; S I Hay
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

9.  Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.

Authors:  Prashant K Mallick; Hema Joshi; Neena Valecha; Surya K Sharma; Alex Eapen; Rajendra M Bhatt; Harish C Srivastava; Patrick L Sutton; Aditya P Dash; Virendra K Bhasin
Journal:  Malar J       Date:  2012-01-11       Impact factor: 2.979

10.  Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.

Authors:  Nicholas J White; Wirichada Pongtavornpinyo; Richard J Maude; Sompob Saralamba; Ricardo Aguas; Kasia Stepniewska; Sue J Lee; Arjen M Dondorp; Lisa J White; Nicholas P J Day
Journal:  Malar J       Date:  2009-11-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.